560 related articles for article (PubMed ID: 14691534)
1. Pten dose dictates cancer progression in the prostate.
Trotman LC; Niki M; Dotan ZA; Koutcher JA; Di Cristofano A; Xiao A; Khoo AS; Roy-Burman P; Greenberg NM; Van Dyke T; Cordon-Cardo C; Pandolfi PP
PLoS Biol; 2003 Dec; 1(3):E59. PubMed ID: 14691534
[TBL] [Abstract][Full Text] [Related]
2. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
Blando J; Portis M; Benavides F; Alexander A; Mills G; Dave B; Conti CJ; Kim J; Walker CL
Am J Pathol; 2009 May; 174(5):1869-79. PubMed ID: 19395652
[TBL] [Abstract][Full Text] [Related]
3. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression.
Graff JR; Konicek BW; McNulty AM; Wang Z; Houck K; Allen S; Paul JD; Hbaiu A; Goode RG; Sandusky GE; Vessella RL; Neubauer BL
J Biol Chem; 2000 Aug; 275(32):24500-5. PubMed ID: 10827191
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.
Zhong C; Saribekyan G; Liao CP; Cohen MB; Roy-Burman P
Cancer Res; 2006 Feb; 66(4):2188-94. PubMed ID: 16489020
[TBL] [Abstract][Full Text] [Related]
5. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
[TBL] [Abstract][Full Text] [Related]
6. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse.
Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795
[TBL] [Abstract][Full Text] [Related]
7. Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.
Xu X; Kobayashi S; Qiao W; Li C; Xiao C; Radaeva S; Stiles B; Wang RH; Ohara N; Yoshino T; LeRoith D; Torbenson MS; Gores GJ; Wu H; Gao B; Deng CX
J Clin Invest; 2006 Jul; 116(7):1843-52. PubMed ID: 16767220
[TBL] [Abstract][Full Text] [Related]
8. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis.
Gao H; Ouyang X; Banach-Petrosky W; Borowsky AD; Lin Y; Kim M; Lee H; Shih WJ; Cardiff RD; Shen MM; Abate-Shen C
Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17204-9. PubMed ID: 15569926
[TBL] [Abstract][Full Text] [Related]
9. Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.
Jendrossek V; Henkel M; Hennenlotter J; Vogel U; Ganswindt U; Müller I; Handrick R; Anastasiadis AG; Kuczyk M; Stenzl A; Belka C
BJU Int; 2008 Aug; 102(3):371-82. PubMed ID: 18476967
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
11. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
12. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
Narayanan NK; Nargi D; Randolph C; Narayanan BA
Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
[TBL] [Abstract][Full Text] [Related]
13. mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Guertin DA; Stevens DM; Saitoh M; Kinkel S; Crosby K; Sheen JH; Mullholland DJ; Magnuson MA; Wu H; Sabatini DM
Cancer Cell; 2009 Feb; 15(2):148-59. PubMed ID: 19185849
[TBL] [Abstract][Full Text] [Related]
14. A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression.
Majumder PK; Grisanzio C; O'Connell F; Barry M; Brito JM; Xu Q; Guney I; Berger R; Herman P; Bikoff R; Fedele G; Baek WK; Wang S; Ellwood-Yen K; Wu H; Sawyers CL; Signoretti S; Hahn WC; Loda M; Sellers WR
Cancer Cell; 2008 Aug; 14(2):146-55. PubMed ID: 18691549
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of Akt-induced keratinocyte transformation.
Segrelles C; Moral M; Lara MF; Ruiz S; Santos M; Leis H; García-Escudero R; Martínez-Cruz AB; Martínez-Palacio J; Hernández P; Ballestín C; Paramio JM
Oncogene; 2006 Feb; 25(8):1174-85. PubMed ID: 16247457
[TBL] [Abstract][Full Text] [Related]
16. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
17. Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development.
Jiao J; Wang S; Qiao R; Vivanco I; Watson PA; Sawyers CL; Wu H
Cancer Res; 2007 Jul; 67(13):6083-91. PubMed ID: 17616663
[TBL] [Abstract][Full Text] [Related]
18. PLZF mediates the PTEN/AKT/FOXO3a signaling in suppression of prostate tumorigenesis.
Cao J; Zhu S; Zhou W; Li J; Liu C; Xuan H; Yan J; Zheng L; Zhou L; Yu J; Chen G; Huang Y; Yu Z; Feng L
PLoS One; 2013; 8(12):e77922. PubMed ID: 24339862
[TBL] [Abstract][Full Text] [Related]
19. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias.
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
Dis Model Mech; 2013 May; 6(3):710-20. PubMed ID: 23471917
[TBL] [Abstract][Full Text] [Related]
20. Loss of ATF3 promotes Akt activation and prostate cancer development in a Pten knockout mouse model.
Wang Z; Xu D; Ding HF; Kim J; Zhang J; Hai T; Yan C
Oncogene; 2015 Sep; 34(38):4975-84. PubMed ID: 25531328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
